Virpax Pharmaceuticals (VRPX) Misses Q2 EPS by 175c
Tweet
Share
E-mailGet Alerts VRPX Hot Sheet
Join SI Premium – FREE
Virpax Pharmaceuticals (NASDAQ: VRPX) reported Q2 EPS of ($1.75).
For earnings history and earnings-related data on Virpax Pharmaceuticals (VRPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- DOJ Unveils $6.5B Healthcare Fraud Crackdown - WSJ
- Bank First National Corp. (BFC) appoints three new directors to board
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
